Generation of mice with a conditional allele for G6pc
- 22 June 2009
- Vol. 47 (9) , 590-594
- https://doi.org/10.1002/dvg.20538
Abstract
Glucose‐6‐phosphatase‐α (G6Pase‐α or G6PC) catalyzes the hydrolysis of glucose‐6‐phosphate to glucose and is a key enzyme in interprandial glucose homeostasis. Mutations in the human G6PC gene, expressed primarily in the liver, kidney, and intestine, cause glycogen storage disease Type Ia (GSD‐Ia), an autosomal recessive disorder characterized by a disturbed glucose homeostasis. For better understanding of the roles of G6Pase‐α in different tissues and in pathological conditions, we have generated mice harboring a conditional null allele for G6pc by flanking Exon 3 of the G6pc gene with loxP sites. We confirmed the null phenotype by using the EIIa‐Cre transgenic approach to generate mice lacking Exon 3 of the G6pc gene. The resulting homozygous Cre‐recombined null mice manifest a phenotype mimicking G6Pase‐α‐deficient mice and human GSD‐Ia patients. This G6pc conditional null allele will be valuable to examine the consequence of tissue‐specific G6Pase‐α deficiency and the mechanisms of long‐term complications in GSD‐Ia. genesis 47:590–594, 2009. Published 2009 Wiley‐Liss, Inc.Keywords
This publication has 14 references indexed in Scilit:
- Optimized Vector for Conditional Gene Targeting in Mouse Embryonic Stem CellsBioTechniques, 2003
- Glycogen storage disease type I: indications for liver and/or kidney transplantationEuropean Journal of Pediatrics, 2002
- Intestinal function in glycogen storage disease type IJournal of Inherited Metabolic Disease, 2002
- Glycogen storage disease type I: indications for liver and/or kidney transplantationEuropean Journal of Pediatrics, 2002
- Ontogeny of the Murine Glucose-6-Phosphatase SystemArchives of Biochemistry and Biophysics, 1998
- Efficient in vivo manipulation of mouse genomic sequences at the zygote stage.Proceedings of the National Academy of Sciences, 1996
- Glucose–6–phosphatase dependent substrate transport in the glycogen storage disease type–1a mouseNature Genetics, 1996
- Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genesNature, 1988
- Cornstarch Therapy in Type I Glycogen-Storage DiseaseNew England Journal of Medicine, 1984
- Continuous Nocturnal Intragastric Feeding for Management of Type 1 Glycogen-Storage DiseaseNew England Journal of Medicine, 1976